Skip to main content
Clinical Trials/IRCT20211009052704N1
IRCT20211009052704N1
Recruiting
Phase 3

Evaluation of the effect of dexmedetomidine on the prevention of postoperative shivering in patients undergoing eye, ear, throat and nose surgeries

Birjand University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
The effect of dexmedetomidine on the prevention of postoperative shivering in patients undergoing eye, ear, throat and nose surgeries.
Sponsor
Birjand University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having informed consent to enter the study
  • ASA Class 1 and 2

Exclusion Criteria

  • Emergency surgery
  • Patients with ASA 3 and above
  • Drug addiction
  • History of Malignant hyperthermia
  • Anaphylaxis
  • Severe cardiovascular disease
  • Severe kidney, lung, liver disease or any Uncontrolled systemic disease
  • History of taking anti\-psychotic drugs, analgesics, narcotics, alcohol, anti\-inflammatory drugs Includes both nsaid and corticosteroids
  • Neuromuscular diseases
  • Thyroid disease, Dysautonomy, Obesity (BMI\> 30\), Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials